SI1307192T1 - Candesartan for treating migraine - Google Patents
Candesartan for treating migraineInfo
- Publication number
- SI1307192T1 SI1307192T1 SI200130524T SI200130524T SI1307192T1 SI 1307192 T1 SI1307192 T1 SI 1307192T1 SI 200130524 T SI200130524 T SI 200130524T SI 200130524 T SI200130524 T SI 200130524T SI 1307192 T1 SI1307192 T1 SI 1307192T1
- Authority
- SI
- Slovenia
- Prior art keywords
- candesartan
- treating migraine
- migraine
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0002353A SE0002353D0 (en) | 2000-06-22 | 2000-06-22 | New use |
EP01941408A EP1307192B1 (en) | 2000-06-22 | 2001-06-15 | Candesartan for treating migraine |
PCT/SE2001/001379 WO2001097807A1 (en) | 2000-06-22 | 2001-06-15 | New use of angiotensin ii antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1307192T1 true SI1307192T1 (en) | 2006-06-30 |
Family
ID=36203892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200130524T SI1307192T1 (en) | 2000-06-22 | 2001-06-15 | Candesartan for treating migraine |
Country Status (1)
Country | Link |
---|---|
SI (1) | SI1307192T1 (en) |
-
2001
- 2001-06-15 SI SI200130524T patent/SI1307192T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1061669A1 (en) | Processes and compositions for water treatment | |
GB0028264D0 (en) | Well treatment | |
AU3097701A (en) | Combinations for treating neoplasms | |
AU1484202A (en) | Method for treating films | |
GB0028269D0 (en) | Well treatment | |
GB0118884D0 (en) | Apparatus for treating objects | |
PL358481A1 (en) | 6-hydroxy-indazole derivatives for treating glaucoma | |
MXPA03001717A (en) | Method for treatment of migraine. | |
EP1581234A4 (en) | Methods for treating migraine | |
EP1267903A4 (en) | Methods for treating glaucoma | |
GB0118349D0 (en) | Apparatus for treating objects | |
GB0118881D0 (en) | Apparatus for treating objects | |
EG24462A (en) | Compounds for treating fundic disaccomodation | |
AU4498201A (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment ofpain | |
EP1327609A4 (en) | Waste water treating device | |
AU1603401A (en) | Pyranoindoles for treating glaucoma | |
IL163716A0 (en) | Device for treating water | |
GB0121048D0 (en) | Apparatus for treating objects | |
GB0118883D0 (en) | Method for treating objects | |
GB0007652D0 (en) | Treatment for fabrics | |
GB0122810D0 (en) | Method for treating objects | |
GB0123897D0 (en) | Method for treating objects | |
SI1307192T1 (en) | Candesartan for treating migraine | |
AU2001244011A1 (en) | Biofiltering device for treating wastewater | |
TW534105U (en) | Device for treating waste water |